Biological perspectives: update on newer antipsychotic drugs: are they evidence based?

Perspect Psychiatr Care. 2011 Oct;47(4):220-6. doi: 10.1111/j.1744-6163.2011.00316.x. Epub 2011 Aug 11.
No abstract available

MeSH terms

  • Antipsychotic Agents / therapeutic use*
  • Cyclooxygenase 2 Inhibitors / adverse effects
  • Dibenzocycloheptenes
  • Evidence-Based Medicine / trends
  • Heterocyclic Compounds, 4 or More Rings / therapeutic use*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects
  • Indoles / adverse effects
  • Isoindoles / therapeutic use*
  • Isoxazoles
  • Lactones / adverse effects
  • Lurasidone Hydrochloride
  • Piperidines / therapeutic use*
  • Psychotic Disorders / drug therapy*
  • Pyridines / adverse effects
  • Serotonin Receptor Agonists / adverse effects
  • Sulfones / adverse effects
  • Thiazoles

Substances

  • Antipsychotic Agents
  • Cyclooxygenase 2 Inhibitors
  • Dibenzocycloheptenes
  • Heterocyclic Compounds, 4 or More Rings
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Indoles
  • Isoindoles
  • Isoxazoles
  • Lactones
  • Piperidines
  • Pyridines
  • Serotonin Receptor Agonists
  • Sulfones
  • Thiazoles
  • rofecoxib
  • tegaserod
  • cerivastatin
  • asenapine
  • Lurasidone Hydrochloride
  • iloperidone